Challenges of Radiotherapy for Head and Neck Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 1816
Special Issue Editor
Interests: head and neck cancer; neuroendocrine neoplasms of the head and neck; melanoma and non-melanoma skin cancer; radiochemotherapy; radiotherapy-related toxicities
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Even with the refinement of surgical techniques, and the introduction of new systemic agents and treatment concepts, radiotherapy remains an indispensable part of the therapeutic armamentarium in head and neck cancer. Thus, the purpose of this Special Issue is to present the novelties and new directions in the field of radiotherapy for head and neck cancer that are already in use or will potentially play an important role in the future. We welcome original research articles or comprehensive review articles that focus on the possibilities of modulation of radiotherapy intensity or its toxicity, new therapeutic combinations, modifications of the tumor microenvironment, technological innovations, and the potential role of artificial intelligence in radiotherapy to achieve better therapeutic results. Hopefully, such a collection of studies will contribute to a clearer picture of what our expectations should be from radiotherapy in head and neck cancer now and in the future.
Prof. Dr. Primož Strojan
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- radiotherapy
- head and neck cancer
- future prospects
- technology
- toxicity
- tumor microenvironment
- artificial intelligence
